Macquarie Group LTD Maravai Lifesciences Holdings, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 221,651 shares of MRVI stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221,651

Previous 450,071 50.75%

Holding current value

$1.25 Million

Previous $3.22 Million 42.86%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $1.56 Million - $2.22 Million	-228,420 Reduced 50.75%	221,651 $1.84 Million
Q2 2024 Aug 09, 2024	BUY	$6.87 - $11.34 $1.17 Million - $1.94 Million	171,009 Added 61.28%	450,071 $3.22 Million
Q1 2024 May 14, 2024	BUY	$5.11 - $8.76 $1.43 Million - $2.44 Million	279,062 New	279,062 $2.42 Million
Q4 2022 Feb 21, 2023	SELL	$12.5 - $24.78 $805,137 - $1.6 Million	-64,411 Reduced 38.73%	101,896 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $334,111 - $492,571	16,219 Added 10.81%	166,307 $4.27 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $575,053 - $827,370	22,075 Added 17.24%	150,088 $4.26 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $2 Million - $3.34 Million	-81,735 Reduced 38.97%	128,013 $4.52 Million
Q4 2021 Feb 11, 2022	BUY	$35.0 - $45.94 $2.15 Million - $2.82 Million	61,478 Added 41.46%	209,748 $8.79 Million
Q3 2021 Nov 12, 2021	SELL	$36.8 - $60.62 $4.32 Million - $7.12 Million	-117,518 Reduced 44.21%	148,270 $7.28 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $45.0 $8.63 Million - $12 Million	265,788 New	265,788 $11.1 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Maravai Lifesciences Holdings, Inc. Transaction History